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Background and aim: Epidemiological data has established increasing adiposity as a risk factor
for incident asthma. However, the mechanisms underlying the association between obesity and
asthma are incompletely understood. In the present paper, we review current knowledge of
possible mechanisms mediating the observed association between obesity and asthma.
Methods: Systematic literature review.
Results: Obesity and asthma share some etiological factors, such as a common genetic predis-
position and effects of in utero conditions, and may also have common predisposing factors
such as physical activity and diet. Obesity results in important changes in the mechanical prop-
erties of the respiratory system which could explain the occurrence of asthma. However, there
are also plausible biological mechanisms whereby obesity could be expected to either cause or
worsen asthma. These include co-morbidities such as gastro-oesophageal reflux, complications
from sleep-disordered breathing, breathing at low lung volumes, chronic systemic inflamma-
tion, and endocrine factors, including adipokines and reproductive hormones. Obesity related
asthma is in general not associated with eosinophilic airway inflammation, and adipokines are
likely to play important roles in the inflammatory pathogenesis of asthma in obese individuals.
Conclusion: The association between obesity and asthma is not straightforward, and further
knowledge is clearly needed, as understanding the underlying mechanisms may lead to new
therapeutic options for this high-risk part of the asthma population.
ª 2013 Elsevier Ltd. All rights reserved.(C.S. Ulrik).
3 Elsevier Ltd. All rights reserved.
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In recent decades, the prevalence of obesity (body mass
index (BMI)  30 kg/m2) has increased dramatically in
the US, and the prevalence is also increasing rapidly
in most European countries, and is estimated to increase
further.1,2 Obesity is associated with a high risk of
chronic diseases, including diabetes and cardiovascular
disease, and thus constitutes a major public health
problem.3
Asthma is also a major health problem estimated to
affect more than 300 million people of all ages and ethnic
backgrounds worldwide.4 Since Camargo et al.5 first
described the association between obesity and asthma,
numerous epidemiologic studies published during the past
decade have demonstrated an increased risk of asthma and
asthma-like symptoms in obese individuals5e8 and,
furthermore, there seems to be a dose response effect of
increasing BMI on asthma incidence.6 Obesity is associated
with increased asthma severity in both children and
adults.9e13 Taylor et al.14 reported that obesity is associ-
ated with increased daily asthma symptoms, missed
workdays, increased use of rescue bronchodilator and an
overall increase in asthma severity. Obesity is also associ-
ated with less likelihood of achieving well-controlled
asthma and less-favourable response to current asthma
therapy.15e21
Preliminary data suggest that obese patients with
asthma demonstrate different asthma phenotypes
compared with patients of normal weight.22e24 The
obese asthma phenotype can be reversed by weight
loss with improvements in lung function, severity of
asthma symptoms, and by that overall asthma control as
well as decreased medication utilization and hospita-
lizations.25e29
The aim of the present review is to give an overview of
the possible mechanisms underlying the observed associa-
tion between obesity and asthma.Methods
A series of searches were carried out, last updated
February 2013, using the database PubMed. The strategy
was intended to be broad in order to maximize the capture
of citations for peer-reviewed publications relevant to
asthma and obesity. The PubMed searches were carried out
using the following algorithm of MeSH terms: Asthma,
asthma-like symptoms AND obesity or overweight, and the
searches were repeated with these terms in combination
with pathogenesis, mechanisms, genetic, epigenetic,
gender, inflammation, oxidative stress, hormones, adipo-
kines, gender and comorbidities. The citation pool was
further supplemented from manual assessment of the
reference lists accompanying other systematic reviews of
aspects related to asthma in obese individuals and from
other publications identified as being relevant for further
review.
Results
The effect of obesity on lung mechanics
The mechanical effects of obesity on respiratory seem to be
relatively straightforward. The most consistently reported
effect of obesity on lung function is a reduction in the
functional residual capacity (FRC), and studies have
revealed an inverse relationship between BMI and FRC.30,31
The FRC is reduced in obese subjects primarily because of
the changes in the elastic properties of the chest wall.32
The retractive forces of the lung parenchyma on the air-
ways are reduced at low lung volumes, and a lower FRC may
unload the airway smooth muscle (ASM), so that it shortens
more when activated either by a physiological increase in
parasympathetic tone or in response to bronchoconstrictor
agents.33 Low tidal volume (VT) may also contribute to a
further reduction in the strain on ASM. Obese humans
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quencies than their lean counterparts.34 Attachment of
each myosin head to actin imparts increased stiffness to the
muscle, hence not only does breathing relaxes ASM, it also
makes it more compliant and easier to stretch with each
breath. The amplitude of fluctuations in force that strain
ASM is closely linked to the peribronchial stress. Stretching
of ASM during breathing causes actin-myosin cross-bridges
to detach: the bigger the tidal volume (stretch), the
greater the ensuing bronkodilatation.35 The cross-bridge
attachment can also increase the stiffness of ASM, making
the muscle harder to stretch. Because obese subjects
breathe with lower VT, the obesity-related reductions in VT
may lead to a self-sustaining loop, i.e. lower VT leading to
smaller ASM strain leading to greater ASM stiffness, and
greater stiffness leads to even less ASM strain with each
tidal breath. The net result is likely to be more substantial
ASM contraction, increased muscle shortening and airway
narrowing. Closing volume, defined as the volume of gas
remaining in the lungs when the small airways begin to
close during a controlled maximum exhalation, normally
increases with age and is also known to be increased in
individuals with airflow limitation. The effects mentioned
above may therefore be enhanced by tidal breathing
around the closing volume.36e39 In morbid obesity, tidal
breathing usually takes place around the closing vol-
ume,40,41 and small airway closure is observed in many
obese subjects during tidal breathing, particularly in the
supine position.40,42,43 It has been suggested that the
repeated opening and closing of peripheral airways that
occurs under such circumstances may lead to rupture ofFigure 1 Schematic presentation of the possible mechanisms th
asthma.alveolar attachments to bronchioles,44 uncoupling the air-
ways from the retractive forces of the lung parenchyma,
and by that lead to worsening of airflow limitation (Fig. 1).
Spirometric variables, such as forced expiratory volume
in 1 s (FEV1) and forced vital capacity (FVC), also tend to
decrease with increasing BMI.45 It has been suggested that
the association between increasing BMI and a decrease in
lung function is due to the fact that adiposity mainly
compresses the chest, also from the sub-diaphragmatic
angle, and by that limits the expansion of the lungs.45,46
However, the exact doseeresponse relationship between
the amount and distribution of body fat and the mechanical
changes remains unknown and further knowledge is clearly
needed.
Obesity, inflammation and asthma
Obesity in humans is, even in the absence of any overt in-
flammatory insult, associated with persistent low-grade
systemic inflammation, and there is increasing evidence
that obesity should be regarded as a pro-inflammatory
state.47 Adiposity contributes to the pro-inflammatory
milieu and is thereby responsible for the formation of
low-grade chronic inflammation in obese individuals.48
Visceral adipose tissue is an important source of cytokine
production. It has been shown that high-sensitivity C-
reactive protein (hsCRP), tumour necrosis factor-alpha
(TNF-a) and interleukin (IL)-6 concentrations is higher in
obese than in non-obese individuals. In obese individuals,
obesity, assessed by BMI, is significantly correlated
with hsCRP concentration, whereas visceral adiposity isat may explain the observed association between obesity and
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ever, the effect of systemic inflammation on airway
inflammation in asthma is debated and only incompletely
understood. The low-grade chronic pro-inflammatory state
seen in obese subjects affects the cellular and molecular
signalling pathways of the immune system, and it has been
proposed that systemic inflammation modulates airway
inflammation and, consequently, the expression of asthma
in obese subjects.50 However, the effects of obesity on
systemic inflammation are unlikely to fully explain the
asthmaeobesity association observed in humans.51,52
A positive correlation between adipocyte diameter and
TNF-a level has been observed and this finding is in
agreement with the known biological relationships between
body fat and metabolic diseases in adults. It emphasize that
subcutaneous adipocyte diameter is an adiposity measure
more closely related to inflammation than BMI or fat mass.
Both BMI and fat mass are surrogate indexes of adipocyte
size.53 Asthma is characterized by the presence of an in-
flammatory cell infiltrate in the bronchial mucosa consist-
ing of activated mast cells, eosinophils, and T-lymphocytes.
Several cytokines are considered to play a pivotal role in
this response, particularly IL-4, IL-5, IL-6, and TNF-alpha.
TNF-a is known to be elevated in uncontrolled, severe
asthma. TNF-a also increases the production of Th2 cyto-
kines such as IL-4 and IL-5 in bronchial epithelium and in
addition, it is involved in the recruitment of neutrophils,
eosinophils, and T cells into the inflammatory zone. IL-4
stimulates activated B-cell and T-cell proliferation, and
the differentiation of CD4þ T-cells into Th2 cells. IL-4 also
plays a pivotal role in the regulation of IgE synthesis and
induces the expression of the low-affinity IgE receptor on
macrophages. IL-5 is a growth and differentiation factor,
activator, and chemo-attractant for eosinophils and as a
consequence is considered a pivotal cytokine in allergen-
and parasite-mediated eosinophilic responses. IL-5 stimu-
lates B cell growth and increase immunoglobulin secretion
Furthermore, TNF-a also increases the production of pro-
inflammatory cytokines such as IL-6 and IL-1b.54 Thus, the
TNF-a inflammatory pathway is common to both obesity
and asthma and it is plausible that this pathway is up-
regulated in the presence of both asthma and obesity,
and by that leading to higher levels of these cytokines due
to the higher levels of TNF-a. TNF receptors are expressed
in ASM cells and TNF-a may increase contractility in
response to airway constrictor agents; or in other words
they might increase airway hyperresponsiveness.55 Airway
hyperresponsiveness is a characteristic feature of asthma
and a causal link between airway inflammation and airway
hyperresponsiveness in asthma is favoured by many.56
However, most studies have not been able to demonstrate
an association between obesity and increased airway
inflammation in asthma.57e60 A prospective study by
Sutherland et al.,61 demonstrated increased IL-1b, IL-5, IL-
6 and IL-8 in sputum supernatants obtained from individuals
with asthma, but no differences were noted between obese
and lean patients leading the authors to conclude that the
obese asthma phenotype is not a result of more pronounced
airway inflammation. TNF is known to act via TNF receptor
1 (TNFR1) and TNF receptor 2 (TNFR2). Zhu et al.62 have, in
obese mice, studied the role of TNFR1 for characteristics of
airway hyperresponsiveness. The authors observed thatobesity resulted in systemic as well as pulmonary inflam-
mation, but that activating TNFR1 seems to protect against
the airway hyperresponsiveness associated with obesity,
and, therefore, may suggest that effects on pulmonary
inflammation contribute to this protection. In another
experimental mice study, Williams et al.63 have shown that
TNFR2 signalling is required for the innate AHR that de-
velops in obese mice, and based on their observations,
suggested that TNFR2 may act by promoting endothelin.
Eosinophil airway inflammation can be quantified by the
percentage of eosinophils in induced sputum or indirectly
by the level of nitric oxide in exhaled breath. However,
previous studies have failed to document an association
between body fat and exhaled nitric oxide, as a marker of
eosinophilic airway inflammation.64 Farah et al.65 reported
residual asthma symptoms in obese patients after anti-
inflammatory treatment leading to significant reductions
in exhaled nitric oxide. Veen et al. studied a group of se-
vere asthmatics in a tertiary care setting, and found that
BMI was inversely related to both sputum eosinophilia and
exhaled nitric oxide.58 The current evidence, therefore,
suggests that obesity does not increase the degree of
eosinophil airway inflammation in asthmatics, and that
obesity related asthma is mediated primarily through non-
eosinophilic pathways.Oxidative stress, obesity and asthma
In case of oxidative stress, either an increased reactive
oxygen species (ROS) production and/or reduced antioxi-
dant defences create an imbalance, allowing for oxidative
insult to occur, which can worsen inflammation and lead to
injury by enhancing pro-inflammatory cytokine release and
altering enzymatic function.66 Compared with non-
asthmatic subjects, subjects with asthma have increased
systemic oxidative stress.67 An increased oxidative stress in
asthma may be associated with an increased production of
lipid peroxidation products and protein carbonyls in
plasma, increased plasma isoprostanes, enhanced genera-
tion of ROS by blood monocytes, neutrophils, and eosino-
phils; increased oxidized glutathione in bronchoalveolar
lavage (BAL) fluid, and increased level of nitric oxide (NO)
in exhaled air. In children, asthma is associated with
increased exhaled breath condensate levels of malondial-
dehyde (MDA) and reduced glutathione.68,69 Glutathione, in
its reduced form, protects airway epithelial cells from free
radicals, while MDA is formed due to the action of reactive
oxygen species on membrane phospholipids and is a marker
of oxidative stress. Ercan et al.70 showed that plasma MDA
levels are increased and glutathione levels are decreased in
children with asthma, with the highest levels of oxidative
stress seen in children with more severe disease. Further-
more, children with asthma had higher plasma levels of 8-
isoprostanes, a prostaglandin and a biomarker of oxida-
tive stress, compared with healthy controls. Montuschi
et al.71 showed that airway oxidative stress could be
assessed by sampling 8-isoprostanes in exhaled breath
condensate (EBC). In their study, the EBC concentration of
8-isoprostanes in asthmatic subjects correlated with the
fraction of exhaled nitric oxide. The concentration of 8-
isoprostanes increased with increasing severity of asthma;
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subjects than in healthy controls. The available data sup-
port the assumption that asthma is associated with
increased oxidative stress.72 However, it is unclear if the
presence of increased airway oxidative stress is a conse-
quence of the more pronounced systemic oxidative stress
seen in obesity.
Obesity is also associated with increased oxidative stress
and systemic inflammation,73 and in cross-sectional studies,
obese subjects have higher levels of oxidative stress bio-
markers compared with their normal-weight counterparts.74
Increased systemic or airway oxidative stressmay, therefore,
potentially be the mechanism linking obesity with increased
asthma severity. Whether or not exhaled 8-isoprostane levels
in asthmatic subjects are correlated with BMI was evaluated
in the study by Komakula et al.75 Sixty-seven patients aged
18e70 years previously diagnosed with moderate to severe
persistent asthma according to the GINA guidelines4 were
enrolled and compared with 47 healthy controls recruited
from the hospital personnel. There was a linear association
between BMI and exhaled 8-isoprostanes in the 67 moderate
to severe adult asthmatic subjects, but not in the 47 healthy
controls. However, no test for interaction was reported, and
the average levels of exhaled 8-isoprostanes were not
different between asthmatic subjects and controls. In a
cross-sectional study, Sood et al.76 investigated the associa-
tion between plasma levels of 8-isoprostanes and BMI and
found that BMI was positively associated with 8-isoprostanes,
but only in women. In the un-adjusted analysis, asthma was
significantly associated with increased 8-isoprostanes, but
this association became non-significant after adjusting for
BMI. Among women, there was a significant association be-
tween increasing BMI and the presence of asthma, whereas
there was no significant association with 8-isoprostanes.
These results suggest that obesity is associated with asthma,
yet this association is not explained by increased systemic 8-
isoprostanes. Holguin et al.77 measured serum and exhaled 8-
isoprostane levels in a cohort of moderate to severe adult
asthmatics. The presence of obesity, but not asthma, was
associated with increased exhaled 8-isoprostane levels. On
the other hand, plasma levels of 8-isoprostanes were higher
in asthmatics, but no effect of obesity was observed. In
addition, there was no correlation between exhaled and
plasma8-isoprostane levels. Based on these data, the authors
inferred that while asthma increases systemic oxidative
stress and obesity increases airway oxidative stress therewas
no synergism between plasma and exhaled 8-isoprostane
levels. It is difficult to make a conclusion regarding the role
of oxidative stress in obese asthmatics given the conflicting
currently available data, but it is plausible that oxidative
stressmay not be a causative factor but rathermaymodulate
asthma severity and alter response to medications.Adipokines in obesity related to asthma
Adipose tissue produces a number of mediators, termed
adipokines, which have significant metabolic effects. One
of these adipokines, named leptin, is secreted by adipose
tissue in direct proportion to the level of adiposity,78 and
acts, under healthy conditions, through the hypothalamus
as an appetite suppressant and metabolic stimulant.79Leptin stimulates the production of inflammatory media-
tors such as TNF-a and IL-6 from the adipose tissue,80,81
TNF-a also promotes the expression and release of leptin
from the adipose tissue,82,83 and thereby establish a posi-
tive feedback mechanism. Leptin promotes CD4 (þ) T
lymphocyte activation towards the Th1 phenotype with
increased production of interferon-g.84e86 Leptin thereby
leads to production of pro-inflammatory cytokines,
including TNF-a, IL-6 and interferon-g, well-known to be
associated with asthma.87,88 However, the effects on Th1
and Th2 cytokines differ. Leptin increases Th1 cytokine
production (IL-2, interferon-g and TNF-a), but decreases
Th2 cytokine production (IL-4, IL-5, and IL-10). These ob-
servations suggest that, if leptin plays a role in asthma, it is
unlikely to be through a traditionally Th2 phenotypes of
asthma. The pro-inflammatory effect of leptin is also
mediated by monocytes, and macrophages respond to lep-
tin through increased lipopolysaccharide (LPS)-stimulated
production of cytokines.81,84,89 Furthermore, leptin is also
capable of promoting angiogenesis and airway remodelling
via vascular endothelial growth factor (VEGF), as VEGF
release from human ASM cells is enhanced following leptin
stimulation.90 Therefore, leptin is assumed to have a more
vital effect on the asthmatic inflammation, and perhaps
also airway remodelling, in obese than in non-obese in-
dividuals suffering from asthma. Sood et al.91 have in a
large cross-sectional, population-based US study showed a
positive association between the highest quartile of serum
leptin concentration and the presence of current doctor-
diagnosed asthma in women. After adjustment for serum
levels of leptin, the relationship between BMI and asthma
was attenuated but remained of borderline significance.
These findings, therefore, suggest that the leptin pathway
may partly explain the obesityeasthma relationship.
Adiponectin levels, in contrast to many of the other
adipokines, decreases in obesity and increases again with
weight loss, and plasma adiponectin levels are, therefore,
inversely related to BMI.92e96 Adiponectin have primary
metabolic effects in the liver and skeletal muscle, including
increased glucose uptake, inhibition of gluconeogenesis,
and increased fatty acid oxidation, and, furthermore, adi-
ponectin also has anti-inflammatory effects.96e101 These
anti-inflammatory effects of adiponectin are inhibition of
the production of the pro-inflammatory cytokines IL-6 and
TNF-a102 and induction of the anti-inflammatory cytokine
IL-1 receptor antagonist and IL-10.103,104 Adiponectin
markedly attenuates allergen induced airway inflammation
in mice105 and adiponectin deficient mice demonstrate
greater eosinophilia in the airways.106 In premenopausal
women, serum adiponectin e proteins mainly produced by
adipocytes which may be pro-inflammatory (such as leptin)
e levels are protective against the development of
asthma.107 Low adiponectin levels have also been associ-
ated with asthma in population studies.108Epigenetic mechanisms associated with obesity and
asthma
There is growing recognition that prenatal and early-life
diet and nutrition may be important for the development of
both asthma and obesity, as well as other diseases. Current
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e.g. apples, fish, and egg, and specific nutrients in prenatal
diet, including antioxidants, vitamin E and C, zinc, sele-
nium, iron, fatty acids, and vitamin D, may influence
asthma and allergies through effects on the neonates im-
mune system and lung development.109e117 Intrauterine
nutrition may influence the risk of subsequent obesity
through perturbations of the central endocrine regulatory
systems and programming the development of adipose tis-
sue in the offspring.118,119 The associations between birth
weight and subsequent obesity and asthma strongly suggest
that prenatal nutrition plays a role in the development of
both of these conditions, although the mechanisms may
differ. However, we do have some evidence suggesting that
the development of obesity and asthma is influenced by
common events. Low birth weight is associated with
increased body fat, primarily abdominal fat, later in life.120
With respect to asthma, Raby et al.121 reported a strong
relationship between low-normal gestational age (born in
the 36th week of gestation or later) and asthma at 6 years
of age. However, they did not observe similar association
between low birth weight and asthma at 6 years of age.
Others have also reported that intrauterine growth retar-
dation is a risk factor for adult asthma.122,123 Low birth
weight is associated with lower level of lung function in
adulthood,124 and small lung size is a known risk factor for
doctor-diagnosed asthma and episodes of wheezing,125
probably because small lung size results in reduced
airway calibre. Several studies have shown that there is a
U-shaped relationship between birth weight and adult BMI,
so that both low and high birth weights are associated with
obesity in adulthood.126e128 Both low and high birth weights
are also associated with later asthma.8,129,130
Because both asthma and obesity appear to have their
roots in utero and in early childhood, common exposures
that predispose individuals to both these conditions may
explain the association. Future research is, therefore,
clearly needed and may, hopefully, provide insight into
these early-life factors and by that facilitate prevention of
these disorders.Genetic influences on asthma and obesity
Asthma and obesity may partly share genetic origin. Hall-
strand et al.131 analysed 1001 monozygotic and 383 dizy-
gotic same-sex twin pairs by using structural equations
models to estimate the magnitude of shared genetic cause
that could explain the association between asthma and
obesity. The authors reported that a substantial proportion
of the phenotypic variation in asthma and obesity was a
result of genetic effects and that a large part of the
covariation between obesity and asthma was controlled by
genetic factors. This study, in line with other studies,
provides evidence for genetic pleiotrophy, i.e. that a
common set of genes increases the susceptibility to both
asthma and obesity. Moreover, their analysis showed that
approximately 8% of the genetic component of obesity is
shared with asthma. In fact, specific regions of the human
genome have been identified as related to both asthma and
obesity. Chromosome 5q contains genes ADRB2 and NR3C1.
ADRB2, the gene that codes for the adrenergic b2 receptor,influences sympathetic nervous system activity and is
important in regulating not only the airway tone but also
the resting metabolic rate. The gene encoding for the b2
adrenergic receptor is located on chromosome 5q31eq32.
The Agr16 polymorphism of this receptor has not been
associated with asthma per se,132 but has been associated
with certain asthma phenotypes, including nocturnal
asthma,133 and treatment response to especially long-
acting b2-agonists,
134 although the clinical importance of
the latter has been disputed. The Gln27 polymorphism of
the b2-adrenergic receptor has been found to be signifi-
cantly associated with obesity.135,136 Polymorphism of the
Gln27 influences the bronchodilator response to b2-ago-
nists.137 NR3C1, which codes for the glucocorticoid recep-
tor, is also located on chromosome 5q31e32, and is related
to both asthma and obesity.138e141 Polymorphism of the
NR3C1 gene is significantly associated with bronchial
asthma and may play an important role in the development
of difficult-to-control asthma,142,143 but the mechanisms
behind this are only incompletely understood. Body fat
distribution is influenced by non-pathologic variations in
the responsiveness to cortisol, and genetic variations in the
glucocorticoid receptor influence the accumulation of
abdominal visceral fat,140 as well as the overall presence of
obesity and overweight.144,145 Individuals with specific
variations in the glucocorticoid receptor are, therefore,
more likely to have both increased BMI and a higher risk for
developing asthma. Furthermore, their increased BMI is
also associated with a higher risk for asthma. Future studies
will hopefully provide further insight into the genetic in-
fluence of the obesityeasthma association.
The TNF-a gene complex is located on chromosome
6p21.3 and influences the immune and inflammatory
response important in both asthma and obesity. Several
studies have found associations between the 308-G/A
polymorphism of the TNF-a gene and both asthma146 and
obesity.147 The NcoI variant in the lymphotoxin-A gene
(LTA, 6p21.3), interacting with the 308-G/A polymorphism
of TNF, has been associated with various asthma-related
phenotypes including atopic asthma,148,149 whereas the
T60N polymorphism of the LTA gene has been associated
with waist circumference and other phenotypes of the
metabolic syndrome.150
Chromosome 12q contains genes for inflammatory cyto-
kines associated with both asthma151 and obesity.151,152
Several variants in the vitamin D receptor gene (VDR,
12q13) have been associated with asthma-related
phenotypes.153e155 Vitamin D metabolites are important
immune-modulatory hormones and are able to suppress
Th2-mediated allergic airway disease.156 In Chinese adults
with asthma, vitamin D deficiency has been associated with
decreased lung function.157 In Italian children, lower levels
of serum vitamin D are associated with reduced lung
function, increased hyperresponsiveness to exercise, and
poorer asthma control.158,159 Finally, some authors160,161
have suggested that chromosome 11q13 is also related to
asthma and obesity, but this is at present controversial.
Chromosome 11q13 contains UCP2, UCP3 and the low-
affinity immunoglobulin E receptor FCεRB. The UCP2 and
UPC3 are uncoupling proteins having an influence on the
metabolic rate,162 but their contribution to variation of
obesity phenotypes in the general population remains
Obesity and asthma: A coincidence or a causal relationship? 1293controversial. Some researchers have even suggested that
the UCP2/UCP3 genes are unlikely to have a substantial
effect on variation in obesity phenotypes in US Cauca-
sians.163 In contrast, the low-affinity immunoglobulin E re-
ceptor has been linked with asthma and some believes that
the low-affinity immunoglobulin E receptor forms part of
the inflammatory response of Th2 cells, whose levels in-
crease in asthma, but not in obesity,164 but also this is
controversial, as some studies have failed to show the ev-
idence for a role of chromosome 11q13 in atopy and
asthma.165,166 However, recent analyses based on the
genome-wide association (GWAS) studies have concluded
that single nucleotide polymorphisms (SNPs) within several
genes showed associations to both BMI and asthma at the
genetic level, but none of these associations were signifi-
cant after correction for multiple testing.167Gender differences in the asthmaeobesity
association
Several cross-sectional studies have found a relationship
between obesity and asthma only in females,168e171 and
many prospective studies have also found either no effect in
men or a greater effect in females than in men.172e175 In a
survey of 19.126 Dutch adults, women with a BMI of >30 had
1.8 times higher risk of self-reported asthma than non-obese
women.176 The observed gender difference may be related
to the sex hormone oestrogen. Adipose tissue is recognized
as metabolically active, and in obesity androgen levels are
increased. However, peripheral aromatisation of andros-
tendione to oestrone and testosterone to oestradiol occurs
within the stroma of adipose tissue.177 During the menstrual
cycle, peak oestrogen levels have been associated with
increased symptoms and decreased pulmonary function in
asthmatic women,178 and independent data from the
Nurses’ Health Study I suggest that exogenous oestrogen is
an independent risk factor for the development of incident
asthma in adult women.179 In line with this, Lange et al.
have reported that postmenopausal women on hormonal
replacement therapy have a slightly higher risk of asthma
and asthma-like symptoms.180 A study on mice has shown
that administration of b-oestradiol in female mice results in
a shift in the immunological reaction from a Th1 to a Th2
type.181 Studies have demonstrated that g-oestradiol in-
creases IL-4 and IL-13 production from blood monocytes,182
and increases both eosinophil recruitment183 and degranu-
lation.184 These effects of oestradiol, therefore, exemplify
those typically found in asthma.
Obesity decreases progesterone levels,185 whereas pro-
gesterone up-regulates the number of b2-receptors. A
reduction in progesterone levels reduces b2-receptor
function, which in turn reduces bronchial smooth muscle
relaxation.186 As described above, the satiety hormone
leptin is produced by adipose tissue and may promote
asthma via effects on immune and inflammatory cells.
Leptin concentrations are 4e6 times greater in severely
obese compared to lean human subjects.187,188 Impor-
tantly, for equivalent BMI, leptin levels are higher in women
than in men.188e190
The relationship between obesity and asthma appears
more clearly in women than men. Taken together, theseresults suggest a modulating effect of sex hormones on the
expression of asthma in obesity, but the pathways involved
needs to be further investigated.Comorbidities of obesity and asthma
Obesity may increase the risk of asthma through its effects
on other disease processes. Comorbidities of obesity, such
as gastroesophageal reflux disease (GERD), sleep-
disordered breathing (SDB), dyslipidaemia, type II dia-
betes, and hypertension may trigger or aggravate asthma.
Obesity increases the risk of both GERD and SDB.191e195
Patients with GERD have a significantly higher risk of con-
current asthma compared with patients without
GERD,196e198 and the same is observed for patients with
SDB.16 GERD can worsen asthma either by direct effects on
airway responsiveness or via aspiration-induced inflamma-
tion. Obesity is associated with relaxation of the gastro-
oesophageal sphincter, resulting in reflux of stomach acid
up the oesophagus and into the airways. Direct contact of
stomach acid with the airways leads to bronchoconstriction
either by microaspiration or by vagally mediated reflux.199
Two large epidemiologic studies have systemically exam-
ined the interrelationships between these conditions.
Multivariate logistic regression analysis of data from over
16.000 participants aged 20e44 in the European Community
Respiratory Health Survey demonstrated that the relation-
ship between obesity (BMI>30) and onset of asthma was
unaffected by adjustment for GERD or habitual snoring.191
Although long-standing GERD is thought to contribute to
on-going airway inflammation in asthma, direct evidence of
such a relationship is, at best, limited.200 Similarly, Sulit
et al.201 demonstrated in a community-based cohort study
of 788 children aged 8e11 years) that adjustment for SDB
attenuated the association between obesity and wheeze,
but did not substantially alter the association between
obesity and asthma. Taken together, these data suggest
that the increased risk of asthma in obese individuals is
independent of GERD and SDB.
Dyslipidaemia is a common comorbidity of obesity. A
recent study from Al-Shawwa et al.202 indicates a higher
prevalence of asthma in children with high serum choles-
terol, suggesting that hypercholesterolemia is a potential
risk factor for asthma independent of obesity, but these
data has not yet been reproduced, and similar studies in
adults are also needed.
Type II diabetes is also a common complication of
obesity. There are data indicating that asthma is less
prevalent in patients with type I diabetes.203 Animals with
experimentally induced type I diabetes also have reduced
airway responsiveness and reduced airway inflammation
following allergen sensitization and challenge, and these
effects are reversed after exogenous administration of
insulin.204e206 It has therefore long been speculated
whether there is a relationship between type II diabetes
and asthma, because type II diabetes is often characterized
by hyperinsulinaemia. A recent report207 indicates a higher
prevalence of insulin resistance among obese children with
asthma versus obese children without asthma, leading to
the assumption that the pro-inflammatory state of insulin
resistance may contribute to the pathogenesis of asthma in
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duced in other studies before valid conclusions may be
drawn.
Hypertension is very common in the obese individ-
ual.208,209 Hypertension leading to diastolic heart failure
and ensuing pulmonary congestion could amplify peribron-
chial oedema as a result of volume expansion. Oedema of
the airways has been proposed to augment airway nar-
rowing by uncoupling the airways from the retractive forces
of the lung parenchyma.210 Increased systemic levels of
endothelin are also common in obesity-related hyperten-
sion211 and endothelin is a potent bronchoconstrictor.212
The association between obesity and asthma symptoms
might be an epiphenomenon, and therefore that the true
association is due to comorbid conditions or lifestyle factors
associated with obesity, however, available evidence of
causation or a significant association is, at best, limited.Impact of environment and behaviour on obesity
and asthma
It is conceivable, that the association between obesity and
asthma might be mediated just through low levels of
physical activity. In the EPIC Norfolk cohort, various in-
dicators of physical activity showed that persons engaged in
more active leisure activities had better respiratory func-
tion than persons with a more sedentary lifestyle, and that
those who were engaged in more vigorous leisureetime
activities had a slower decline in FEV1.
213 In a longitudinal
study, daily physical activity was positively related to FVC
but not to FEV1.
214 Rasmussen et al.215 have shown that
increased physical fitness is associated with decreases in
the relative risk of incident asthma in schoolchildren.
Active cigarette smoking has been associated with the
development of asthma in some studies.216e218 However,
the association between BMI and asthma remains even after
adjusting for smoking. Unemployment is directly associated
with higher BMI219,220 and there is also an independent as-
sociations between BMI, limited physical activity and
spending many hours on TV-watching.220 It is conceivable,
that obese people are more likely to stay at home and
thereby are more exposed to the indoor surroundings, and
it is well known that exposure to e.g. allergens and chem-
icals in the indoor environment can lead to the develop-
ment of asthma.221,222
Patients with asthmamay be at increased risk of becoming
obese if they avoid exercise, which might trigger their
symptoms, and/or as an adverse effect of corticosteroid
therapy. However, prospective longitudinal studies have
shown that obesity antedates asthma.223e225 The largest
prospective study226 followed over 135.000 Norwegian men
and women for an average of 21 years. Asthma was self-
reported, and height and weight were measured at base-
line. Inmen, beginning at a BMI of 20, the incidenceof asthma
increased steadily at a rate of 10% per unit increase in BMI. In
women, there was a 7% increase in the incidence of asthma
per unit increase in BMI, beginning at a BMI of 22.While in this
study, the relationship between obesity and asthma was at
least as strong in men as in women, gender differences in the
relationship between obesity and asthmahave been reported
by others (see gender differences above).Discussion
There is substantial evidence that obesity and asthma are
related. Obesity-associated asthma may be a unique
phenotype of asthma, characterized by decreased lung
volumes, more pronounced symptoms, less likelihood of
achieving good asthma control, non-eosinophilic airway
inflammation and a less-favourable response to controller
medication. Whether this relationship between obesity and
asthma is causal or represents co-morbidity due to other
factors is not yet clear. Since obesity is a component of the
metabolic syndrome, which is also associated with systemic
inflammation, it is to be expected that there is a relation-
ship between the metabolic syndrome and asthma.227 In
some studies, insulin resistance or metabolic syndrome is a
stronger risk factor than body mass. There is growing evi-
dence of the influence of hyperglycemia, hyperinsulinemia,
and insulin-like growth factors on airway structure and
function.228 In a large population-based study in Korea,
with over 10,000 participants, the presence of the
metabolic syndrome was associated with asthma-like
symptoms.229
Up until now, several studies exploring the link between
obesity and the prevalence and incidence of asthma in
adults have been published, the majority of these studies
concluded that antecedent obesity was associated with a
significant increased annual risk of a new diagnosis of
asthma. In addition, there was a doseeresponse effect to
this relationship, with increasing BMI being associated with
increasing odds of incident asthma.6 The question has been
raised whether the link between asthma and obesity is real
or may be due to misdiagnosis of asthma in obese persons
complaining of breathlessness. Pakhale et al.230 have
studied the possible misdiagnosis of asthma in obese people
and concluded that obese subjects with urgent health-care
visits for respiratory symptoms were most likely to receive
a misdiagnosis of asthma. Misdiagnosis of asthma was re-
ported to occur in up to 30% of patients. Health-care pro-
viders, and not least doctors, should adhere to guidelines
and seek to objectively confirm a diagnosis of asthma in
order to avoid falsely labelling some obese patients as
having asthma. Moreover, most of the published studies
have relied on self-reporting of physician diagnosis of
asthma and/or recall questionnaires for respiratory symp-
toms and medications. This is a major caveat for most
asthma and obesity studies thus far. Aaron et al.231
demonstrated in a randomly selected Canadian adult pop-
ulation that about 30% of self-reported physician-diagnosed
subjects with asthma, obese and normal weight alike, did
not have objective physiologic evidence of asthma and
presumably received a misdiagnosis.
It has been indicated that asthma is not homogeneous
and that the association between asthma and obesity may
be more for certain phenotypes of asthma. Emerging data
suggest at least two possible distinct phenotypes of obese
asthma patients1: early-onset, atopic asthma that is
complicated by coexisting obesity (found in both sexes)
and2 late-onset, non-atopic asthma that is caused by
obesity (found predominantly in women).232,233 Especially,
obese individuals with non-atopic asthma are increasingly
recognized as a distinct phenotype, and their underlying
Obesity and asthma: A coincidence or a causal relationship? 1295pathophysiology are likely to be different from the typical
lymphocytic and eosinophilic inflammation found in atopic
asthma.233
Early- and late-onset asthma are recognized as distinct
asthma phenotypes with unique clinical and genetic fea-
tures.234 Subjects with early-onset asthma (<12 years of
age) have a higher likelihood of allergic sensitization and
symptoms, a history of eczema, and tend to have higher IgE
levels; in contrast, subjects with late-onset asthma have
less atopy but greater airway eosinophilic inflammation.235
On the basis of early and late-onset asthma appearing to be
different phenotypes, it is reasonable to hypothesize that
they are differentially affected by increases in BMI. Moore
et al.236 have also identified a unique group of mostly older
obese women with late-onset non-atopic asthma, moderate
reductions in FEV1, and frequent need for bursts of oral
corticosteroid to manage exacerbations as novel asthma
phenotypes. Although the longitudinal or cumulative ef-
fects of obesity on asthma are not known in subjects with
early-onset asthma, obesity has been shown to be an in-
dependent risk factor for unremitting asthma beyond pu-
berty.237 This suggests that there is an early-onset asthma
phenotype in which obesity plays a role in the development
of persistent asthma. In subjects with late-onset asthma,
there are, at least to our knowledge, no studies to date that
have evaluated the longitudinal effect of obesity on asthma
outcomes or biomarkers of disease activity.
Conclusions
Obesity is associated with a unique asthma phenotype
characterized by more severe disease and with variable
response to conventional asthma therapies. The mecha-
nistic basis for the association between obesity and asthma
is not known, although mechanical, immunological, ge-
netic, epigenetic, hormonal, and environmental pathways
have all been proposed. At present it is unclear which of
these various pathways that is the dominant mechanism.
However, we believe that the systemic inflammation in
obesity up-regulates the asthmatic pathway, and this is
modified by adipokines and other systemic inflammatory
markers. We favour the hypothesis that adipokines play
important roles in the inflammatory pathogenesis of asthma
in obese individuals. Further understanding of the mecha-
nisms mediating the obese-asthma phenotype would have
significant implications for millions of people suffering from
asthma and we therefore encourage and look forward to
further work on this important topic.
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